rnr-2 Antibody

What is RNR-2 and what is its significance in cellular biology?

RNR-2, also known as ribonucleotide reductase subunit R2 (RNR-R2) or ribonucleoside-diphosphate reductase subunit M2 (RRM2), is a rate-limiting subunit of the enzyme that catalyzes the formation of deoxyribonucleotides from ribonucleotides. This 45 kDa protein (389 amino acids) plays a critical role in regulating the total rate of DNA synthesis to maintain a constant DNA-to-cell mass ratio during cell division and DNA repair processes . RNR-2 undergoes post-translational modifications, particularly phosphorylation at Ser20 and Thr33 residues, which contribute to its regulation and may result in multiple bands when analyzed by Western blotting . The protein's essential role in DNA synthesis makes it an important subject for research in cell cycle studies, cancer biology, and therapeutic development.

What types of RNR-2 antibodies are currently available for research applications?

Several types of RNR-2 antibodies are available for research applications, including:

These antibodies vary in their epitope specificity, with some targeting specific regions of the RNR-2 protein. The selection of an appropriate antibody depends on the intended application, target species, and specific experimental requirements .

How is the specificity of RNR-2 antibodies validated for research purposes?

The validation of RNR-2 antibodies involves multiple complementary approaches to ensure specificity and reliability:

• Western blot analysis demonstrating specific detection of the protein at the expected molecular weight (approximately 45 kDa) in multiple cell types, such as HeLa, MCF7, NIH3T3, and Xenopus eggs .

• Immunoprecipitation assays showing enrichment of the target protein from cell lysates, as demonstrated with CHO cells .

• Immunofluorescence staining confirming the expected subcellular localization, primarily nuclear for RNR-2.

• Cross-reactivity testing with multiple species to establish the range of experimental models where the antibody can be reliably used.

• Citations in peer-reviewed publications, such as the study by Takada et al. on the identification of ribonucleotide reductase protein R1 as an activator of microtubule nucleation in Xenopus egg mitotic extracts .

What are the optimal protocols for using RNR-2 antibodies in Western blotting?

For optimal Western blot results with RNR-2 antibodies, researchers should follow these methodological guidelines:

• Sample preparation: Extract proteins from cells or tissues using appropriate lysis buffers containing protease and phosphatase inhibitors to preserve post-translational modifications.

• Protein quantification: Load 20 μg of protein per lane based on successful detection in reference studies .

• Electrophoresis: Separate proteins using SDS-PAGE (10-12% gels typically work well for a 45 kDa protein).

• Transfer: Transfer proteins to nitrocellulose or PVDF membranes using standard wet or semi-dry methods.

• Blocking: Block membranes with 5% non-fat dry milk or BSA in TBS-T for 1 hour at room temperature.

• Primary antibody incubation: Dilute RNR-2 antibodies at 1/1,000-1/2,000 in blocking buffer and incubate overnight at 4°C .

• Washing: Wash membranes 3-5 times with TBS-T.

• Secondary antibody incubation: Apply appropriate HRP-conjugated secondary antibody for 1 hour at room temperature.

• Detection: Visualize using chemiluminescence detection systems.

Note that multiple bands may be observed due to phosphorylation states at Ser20 and/or Thr33 in human samples, which should not be confused with non-specific binding .

How can researchers optimize immunoprecipitation protocols using RNR-2 antibodies?

To optimize immunoprecipitation (IP) of RNR-2:

• Cell lysis: Use non-denaturing lysis buffers (e.g., RIPA or NP-40 based) that preserve protein-protein interactions while effectively solubilizing membrane-associated proteins.

• Pre-clearing: Incubate lysates with protein A/G beads for 1 hour at 4°C to reduce non-specific binding.

• Antibody binding: Incubate cleared lysates with RNR-2 antibody at 1/300-1/1,000 dilution overnight at 4°C .

• Immunoprecipitation: Add protein A/G beads and incubate for 2-4 hours at 4°C with gentle rotation.

• Washing: Perform 4-6 washes with lysis buffer to remove non-specifically bound proteins.

• Elution: Elute bound proteins by boiling in Laemmli sample buffer.

• Analysis: Analyze immunoprecipitates by Western blotting alongside input controls to confirm enrichment.

This method has been successfully demonstrated with CHO cells, comparing crude extracts to immunoprecipitated samples to verify specific pulldown of RNR-2 .

What are the key considerations for immunofluorescence staining using RNR-2 antibodies?

For successful immunofluorescence staining with RNR-2 antibodies:

• Fixation: Fix cells with 4% paraformaldehyde for 15-20 minutes at room temperature to preserve cellular architecture while maintaining antigenicity.

• Permeabilization: Permeabilize with 0.1-0.5% Triton X-100 for 5-10 minutes to allow antibody access to intracellular targets.

• Blocking: Block with 5% normal serum from the species of the secondary antibody for 30-60 minutes.

• Primary antibody: Incubate with RNR-2 antibody diluted 1/100-1/1,000 in blocking buffer overnight at 4°C .

• Washing: Wash 3-5 times with PBS to remove unbound antibody.

• Secondary antibody: Apply fluorescently-labeled secondary antibody for 1 hour at room temperature, protected from light.

• Counterstaining: Counterstain nuclei with DAPI or Hoechst dye.

• Mounting: Mount using anti-fade mounting medium.

• Imaging: Capture images using confocal or fluorescence microscopy.

Researchers should include appropriate controls and verify the nuclear localization pattern expected for RNR-2. Co-staining with cell cycle markers can provide valuable contextual information, as RNR-2 expression is cell cycle-dependent.

How should RNR-2 antibodies be utilized for immunohistochemistry on paraffin-embedded tissues?

For immunohistochemistry (IHC) on paraffin-embedded tissues using RNR-2 antibodies:

• Deparaffinization: Deparaffinize sections in xylene and rehydrate through graded alcohols to water.

• Antigen retrieval: Perform heat-induced epitope retrieval using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) for 15-20 minutes.

• Endogenous peroxidase blocking: Block endogenous peroxidase activity with 3% hydrogen peroxide for 10 minutes.

• Protein blocking: Apply protein block (serum-free or normal serum) for 10-30 minutes.

• Primary antibody: Incubate with RNR-2 antibody diluted approximately 1/300 overnight at 4°C .

• Washing: Wash thoroughly with PBS or TBS.

• Secondary antibody: Apply biotinylated or polymer-based detection system according to manufacturer's recommendations.

• Development: Visualize with DAB (3,3'-diaminobenzidine) or other chromogen.

• Counterstaining: Counterstain with hematoxylin, dehydrate, and mount.

Researchers should include positive control tissues known to express RNR-2 and negative controls (omitting primary antibody) in each staining run. Evaluation should consider both staining intensity and distribution patterns, particularly in proliferating cells.

How can researchers investigate cell cycle-dependent regulation of RNR-2 using antibody-based techniques?

To study cell cycle-dependent regulation of RNR-2:

• Cell synchronization: Synchronize cells using methods such as double thymidine block, serum starvation/refeeding, or nocodazole treatment.

• Time-course sampling: Collect cells at defined intervals throughout the cell cycle.

• Western blot analysis: Perform Western blotting with RNR-2 antibodies to track protein expression levels.

• Phosphorylation analysis: Use phospho-specific antibodies (if available) or general phospho-detection methods to monitor post-translational modifications of RNR-2.

• Flow cytometry: Combine DNA content analysis (propidium iodide staining) with intracellular RNR-2 immunostaining to correlate expression with cell cycle phases at the single-cell level.

• Immunofluorescence microscopy: Co-stain for RNR-2 and established cell cycle markers (cyclins, Ki-67) to visualize expression patterns throughout the cell cycle.

• ChIP analysis: Investigate transcriptional regulation of RNR-2 during cell cycle progression.

This multi-method approach can provide comprehensive insights into how RNR-2 protein levels and modifications fluctuate throughout the cell cycle and how these changes correlate with DNA synthesis activity.

What methodological approaches can distinguish between different phosphorylation states of RNR-2?

To differentiate between phosphorylation states of RNR-2:

• Phospho-specific antibodies: Utilize antibodies specifically targeting phosphorylated Ser20 or Thr33 residues of RNR-2, if available.

• Phosphatase treatment: Treat duplicate samples with lambda phosphatase prior to SDS-PAGE to confirm that multiple bands are due to phosphorylation rather than other modifications or degradation products.

• Phos-tag SDS-PAGE: Incorporate Phos-tag acrylamide into gels to enhance mobility shifts of phosphorylated proteins, allowing separation of differently phosphorylated forms.

• 2D gel electrophoresis: Separate proteins by isoelectric point followed by molecular weight to resolve different phosphorylation states.

• Immunoprecipitation followed by phospho-specific Western blotting: Pull down total RNR-2 and then probe with phospho-specific antibodies.

• Mass spectrometry: Perform IP of RNR-2 followed by tryptic digestion and LC-MS/MS analysis to identify and quantify specific phosphorylation sites.

Understanding the phosphorylation status of RNR-2 is critical as these modifications at Ser20 and Thr33 residues have been implicated in regulating enzyme activity and stability .

How can protein-protein interaction studies with RNR-2 be conducted using antibody-based approaches?

For investigating RNR-2 protein-protein interactions:

• Co-immunoprecipitation (Co-IP): Use RNR-2 antibodies to pull down protein complexes, followed by Western blotting for suspected interaction partners. This approach has successfully identified interactions in previous studies, such as the relationship between RNR protein R1 and microtubule nucleation .

• Reverse Co-IP: Immunoprecipitate putative interaction partners and probe for RNR-2 to confirm bidirectional interaction.

• Proximity ligation assay (PLA): Use primary antibodies against RNR-2 and potential interacting proteins, followed by secondary antibodies conjugated to oligonucleotides that generate fluorescent signals when proteins are in close proximity (<40 nm).

• FRET (Förster Resonance Energy Transfer): Utilize fluorescently labeled antibodies against RNR-2 and interaction partners to detect energy transfer indicative of close molecular proximity.

• Chromatin immunoprecipitation (ChIP): If studying transcription factors that regulate RNR-2 expression.

• Tandem affinity purification followed by mass spectrometry: For unbiased identification of RNR-2 interaction partners.

These methods can reveal important functional relationships, such as interactions with cell cycle regulators, DNA damage response proteins, or metabolic enzymes that coordinate nucleotide synthesis with cellular demands.

What are common technical challenges when working with RNR-2 antibodies and how can they be resolved?

Common challenges and solutions when working with RNR-2 antibodies:

• Multiple bands in Western blots:

  • Challenge: Distinguishing between phosphorylation-related bands and non-specific binding

  • Solution: Include phosphatase-treated controls; compare with expected molecular weight (45 kDa)

• Weak or absent signal:

  • Challenge: Insufficient antigen detection

  • Solution: Optimize antibody concentration; enhance antigen retrieval; increase protein loading; try alternative antibodies targeting different epitopes

• High background:

  • Challenge: Non-specific binding

  • Solution: Increase blocking time/concentration; optimize antibody dilution; lengthen washing steps; use more stringent washing buffers

• Inconsistent immunoprecipitation:

  • Challenge: Variable pull-down efficiency

  • Solution: Pre-clear lysates; optimize antibody-to-bead ratio; ensure antibody compatibility with IP buffer conditions

• Cell-type specific variations:

  • Challenge: Differential expression or accessibility of epitopes

  • Solution: Validate antibody performance in each specific cell type; consider known expression patterns (as demonstrated across HeLa, MCF7, NIH3T3, and other cell types)

• Fixation-sensitive epitopes in IF/IHC:

  • Challenge: Epitope masking during fixation

  • Solution: Test alternative fixation methods; optimize antigen retrieval protocols

Understanding these challenges and implementing appropriate technical adjustments can significantly improve experimental outcomes.

What quality control parameters should be evaluated when selecting RNR-2 antibodies?

Key quality control parameters to evaluate when selecting RNR-2 antibodies:

• Specificity validation:

  • Western blot showing band at expected molecular weight (45 kDa)

  • Absence of signal in knockout/knockdown controls

  • Peptide competition assays demonstrating specificity

• Application validation:

  • Demonstrated performance in intended applications (WB, IP, IF, IHC)

  • Optimized protocols for specific applications

  • Representative images showing expected results

• Species reactivity:

  • Confirmed cross-reactivity with species of interest (human, mouse, rat, hamster, Xenopus, etc.)

  • Sequence alignment of the epitope region across species

• Sensitivity:

  • Lower limit of detection documented

  • Signal-to-noise ratio in relevant applications

• Reproducibility:

  • Lot-to-lot consistency data

  • Inter-laboratory validation if available

• Literature validation:

  • Citations in peer-reviewed publications

  • Published data using the antibody in relevant research contexts

• Epitope information:

  • Known epitope region

  • Potential cross-reactivity with related proteins assessed

• Technical support:

  • Detailed protocols available

  • Troubleshooting guidance provided

Thorough evaluation of these parameters before purchasing can save significant time and resources in experimental optimization.

How can researchers validate a new lot of RNR-2 antibody before implementing it in critical experiments?

To validate a new lot of RNR-2 antibody before implementation in critical experiments:

• Side-by-side comparison:

  • Run new and previous lots on identical samples

  • Compare signal intensity, specificity, and background

• Positive control testing:

  • Test on samples known to express RNR-2 (such as HeLa, MCF7, NIH3T3 cells)

  • Verify expected molecular weight and band pattern

• Application-specific validation:

  • Validate specifically for each intended application (WB, IP, IF, IHC)

  • Optimize conditions for the new lot

• Blocking peptide competition:

  • Perform parallel experiments with antibody pre-incubated with immunizing peptide

  • Confirm signal elimination in blocked sample

• Cross-reactivity assessment:

  • Test on multiple species if cross-species experiments are planned

  • Verify reactivity with human, mouse, rat, hamster, or Xenopus samples as needed

• Phosphorylation state detection:

  • Confirm ability to detect phosphorylated forms if relevant to research

  • Compare multiple band patterns with previous lot

• Documentation:

  • Record lot number, validation results, and optimized protocols

  • Maintain documentation for reproducibility and troubleshooting

This systematic validation approach ensures experimental continuity and reliability when transitioning to new antibody lots.

How can computational antibody design technologies enhance RNR-2 antibody development?

Recent advances in computational antibody design technologies offer significant potential for enhanced RNR-2 antibody development:

• Structure-based design: RFdiffusion technology enables atomically accurate de novo design of antibodies targeting specific epitopes on proteins like RNR-2 . This allows rational design of antibodies with specific binding properties rather than relying solely on immunization and screening.

• Epitope-specific targeting: Computational approaches can design antibodies targeting functionally important domains of RNR-2, such as regulatory phosphorylation sites (Ser20, Thr33) or interaction interfaces with other proteins .

• Enhanced prediction accuracy: Fine-tuned networks like RoseTTAFold2 and AlphaFold3 improve prediction of antibody-antigen complex structures, enabling better selection of candidates before experimental testing .

• Framework optimization: Computational methods allow preservation of highly optimized therapeutic antibody frameworks while designing novel complementarity-determining regions (CDRs) for specific epitope targeting .

• Reduced experimental screening: By selecting the most promising candidates computationally, researchers can reduce the number of antibodies that need experimental validation, accelerating development timelines and reducing costs.

These approaches could lead to highly specific RNR-2 antibodies capable of distinguishing between different functional states or targeting conserved epitopes across species.

What novel applications of RNR-2 antibodies are emerging in cancer research and therapy development?

Emerging applications of RNR-2 antibodies in cancer research and therapy development include:

• Therapeutic antibody development: As RNR-2 is often overexpressed in cancer cells to support increased DNA synthesis, antibodies that can inhibit its function represent potential therapeutic agents.

• Biomarker detection: RNR-2 antibodies enable quantification of RNR-2 as a potential biomarker for cancer progression, treatment response, and prognosis.

• Antibody-drug conjugates (ADCs): RNR-2-targeting antibodies can be coupled with cytotoxic payloads to deliver targeted therapy to cancer cells with elevated RNR-2 expression.

• Combination therapy monitoring: Antibodies that can detect changes in RNR-2 expression or phosphorylation state in response to chemotherapy or radiation allow for monitoring of treatment efficacy.

• Imaging applications: Fluorescently labeled or radiolabeled RNR-2 antibodies enable visualization of RNR-2 expression in tumors through techniques like immunoPET.

• Cell cycle checkpoint studies: RNR-2 antibodies facilitate investigation of connections between nucleotide metabolism and cell cycle checkpoint regulation in cancer cells.

These applications leverage the critical role of RNR-2 in DNA synthesis and cell proliferation, processes that are frequently dysregulated in cancer.

How can multiplexed antibody-based approaches be optimized for studying RNR-2 in complex cellular pathways?

Optimization strategies for multiplexed antibody-based approaches to study RNR-2 in complex pathways:

• Cyclic immunofluorescence (CycIF):

  • Incorporate RNR-2 antibodies into sequential staining panels

  • Use fluorophore-conjugated secondary antibodies

  • Include antibodies against regulatory proteins and downstream effectors

  • Employ signal removal between cycles to prevent cross-talk

• Mass cytometry (CyTOF):

  • Label RNR-2 antibodies with rare earth metals

  • Design panels including cell cycle markers, DNA damage response proteins, and metabolic enzymes

  • Analyze single-cell data with dimensional reduction techniques

  • Correlate RNR-2 expression with cell phenotypes

• Multiplex immunohistochemistry:

  • Optimize antibody combinations for sequential or simultaneous detection

  • Use spectral unmixing to separate closely related fluorophores

  • Include spatial analysis to identify co-localization patterns

  • Correlate with clinical outcomes in patient samples

• Proximity-based assays:

  • Apply proximity ligation or proximity extension assays to detect RNR-2 interactions

  • Develop multiplexed protocols to simultaneously assess multiple interaction partners

  • Incorporate subcellular localization information

• Single-cell technologies:

  • Combine antibody-based protein detection with single-cell RNA sequencing

  • Integrate proteomic and transcriptomic data to understand RNR-2 regulation

  • Apply computational approaches to identify pathway relationships

These multiplexed approaches provide systems-level insights into how RNR-2 functions within complex cellular networks controlling DNA synthesis, cell cycle progression, and response to genotoxic stress.